Pfizer: Mastering The Art Of The Deal With Metsera - Upgraded To Buy (NYSE:PFE)

PPfizer Inc.'s (NYSE: PFE ) name has been frequently in the headlines lately. In addition to making a deal with the U.S. administration to offer direct-to-consumer discounted drugs, the company also made a bold comebackI’ve managed my investments since 1999, gaining perspective across multiple market cycles. With a background in Economics from the University of Tartu and ongoing CFA certification, I focus on uncovering deeply undervalued equities with long-term potential often overlooked by the market.Analy ...